Following positive trial findings , retatrutide, a new peptide option for treating non-insulin dependent diabetes , has secured conditional approval from Great Britain's Drug and Regulatory Agency ( MHRA https://deborahfqas308086.blogginaway.com/42011353/retatrutide-medication-peptide-british-green-light-and-launch